[11C]PBB3, developed by Higuchi and his colleagues, is a clinically used PET tracer allowed in vivo detection of tau inclusions in Alzheimer’s disease as well as non-AD tauopathies in the human brain. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.